by Shim Seongah
Published 17 Oct.2024 17:23(KST)
HLB Life Science announced on the 17th that a stock pledge agreement involving a change in the largest shareholder has been signed.
The pledge provider is HLB, owning 20,695,725 shares, accounting for 17.44% of the stake. The creditor, Mirae Asset Securities, has set a total collateral amount of 150 billion KRW, with 20,695,725 shares pledged as collateral. The collateral period is from the 21st of this month to November 21st.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.